Rifaximin for bloating caused by SIBO
Treatments studied
Part of Digestive system, Infections clinical trials.
This study tests whether the antibiotic rifaximin can relieve bloating in people with small intestinal bacterial overgrowth (SIBO). If you have chronic bloating and a positive SIBO breath test, this trial may be a good fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old.
- Your main stomach problem is bloating or a feeling of fullness (more than pain or other symptoms).
- You have tested positive for small intestinal bacterial overgrowth (SIBO) on a breath test.
- You are not pregnant or breastfeeding.
- You have not taken antibiotics or probiotics in the last 2 weeks, and no stomach medications in the last week.
- You do not have serious health conditions like cancer, kidney disease, or diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a probiotic pill for people with bothersome bloating and an abnormal hydrogen breath test. It aims to see if the probiotic helps improve gut symptoms.
This study looks at whether certain bacteria in the small intestine cause abdominal bloating and distension. It aims to help understand this common problem and find better ways to treat it.
This study tests how Rifaximin (a medicine for SIBO) affects the bacteria and other substances in your gut. You'll swallow a small capsule that collects samples as it travels through your digestive system, so researchers can see how your gut changes during treatment.
This study tests whether rifaximin, an antibiotic that works in the gut, can reduce bloating in people with irritable bowel syndrome, constipation, or functional bloating. Rifaximin may help by changing the balance of bacteria in your intestines.
This trial tests whether adding a probiotic supplement to standard antibiotic therapy (rifaximin) works better than the antibiotic alone for treating small intestinal bacterial overgrowth (SIBO) in people with irritable bowel syndrome (IBS). If you have IBS and SIBO, this study could help find a more effective treatment.
This trial looks at whether an overgrowth of bacteria in the small intestine causes bloating. It tests how well treatment works for people with functional bloating (bloating without a clear cause) who also have this bacterial overgrowth.
Hear when a new SIBO trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.